These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1888169)

  • 1. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a PDGF-responsive element in the murine c-myc gene.
    Sacca R; Cochran BH
    Oncogene; 1990 Oct; 5(10):1499-505. PubMed ID: 2250909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the c-myc P2 promoter.
    Moberg KH; Tyndall WA; Pyrc J; Hall DJ
    J Cell Physiol; 1991 Jul; 148(1):75-84. PubMed ID: 1860897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cells.
    Eliopoulos A; Kerr DJ; Spandidos DA
    Anticancer Res; 1991; 11(6):2153-7. PubMed ID: 1776855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
    Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Xenopus c-myc promoter activity in oocytes and embryos.
    Modak SP; Principaud E; Spohr G
    Oncogene; 1993 Mar; 8(3):645-54. PubMed ID: 8437848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
    Berberich SJ; Postel EH
    Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
    Gutsch DE; Marcu KB; Kenney SC
    Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the c-myc but not the cH-ras promoter by platinum compounds.
    Eliopoulos AG; Kerr DJ; Maurer HR; Hilgard P; Spandidos DA
    Biochem Pharmacol; 1995 Jun; 50(1):33-8. PubMed ID: 7605342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two regulatory domains are required for downregulation of c-myc transcription in differentiating U937 cells.
    Skerka C; Zipfel PF; Siebenlist U
    Oncogene; 1993 Aug; 8(8):2135-43. PubMed ID: 8336940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexamethylene bisacetamide and cis-platin stimulate the expression from the HIV-1 long terminal repeat sequence in human MCF-7 cells.
    Tsatsanis C; Tsiriyotis C; Spandidos DA
    In Vivo; 1992; 6(2):145-9. PubMed ID: 1525334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory domains within the P0 promoter of human c-myc.
    Lang JC; Wilkie NM; Clark AM; Chudleigh A; Talbot S; Whitelaw B; Frame MC
    Oncogene; 1991 Nov; 6(11):2067-75. PubMed ID: 1945411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by cis-platin.
    Spandidos DA; Zoumpourlis V; Kotsinas A; Maurer HR; Patsilinacos P
    Genet Anal Tech Appl; 1990 Sep; 7(5):138-41. PubMed ID: 1965411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins.
    Lipp M; Schilling R; Bernhardt G
    Oncogene; 1989 May; 4(5):535-41. PubMed ID: 2471129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of human immunodeficiency virus long terminal repeat to growth factors and hormones.
    Spandidos DA; Zoumpourlis V; Kotsinas A; Tsiriyotis C; Sekeris CE
    Anticancer Res; 1990; 10(5A):1241-5. PubMed ID: 2241099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells.
    Eliopoulos A; Kerr DJ; Spandidos DA
    Anticancer Drugs; 1991 Dec; 2(6):597-601. PubMed ID: 1806037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of the human c-myc gene by simian virus 40 large T antigen without binding to p53 and RB proteins in the transient expression system.
    Shimazu T; Takada S; Ishida S; Ueno Y; Koike K
    Biochem Biophys Res Commun; 1997 Jun; 235(1):153-7. PubMed ID: 9196053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of upstream regulatory elements that repress expression of adult beta-like globin genes in a primitive erythroid environment.
    Ebb D; Tang DC; Drew L; Chin K; Berg PE; Rodgers GP
    Blood Cells Mol Dis; 1998 Sep; 24(3):356-69. PubMed ID: 10087993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.